Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Karin Welen"'
Autor:
Malin Sund, Andreas Josefsson, Osvaldo Fonseca-Rodríguez, Anne-Marie Fors Connolly, Karin Welen
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/3fe6a03c41814ae090f30747272d6dba
Autor:
Karin Welen, Ebba Rosendal, Eva Freyhult, Anne-Marie Fors Connolly, Anna K. Överby, Andreas Josefsson
Publikováno v:
European urology. 81(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c413e006e427bbe13e3da559aede77e
https://pubmed.ncbi.nlm.nih.gov/34980495
https://pubmed.ncbi.nlm.nih.gov/34980495
Publikováno v:
Methods and Protocols, Vol 6, Iss 6, p 118 (2023)
Bone metastases cause morbidity and mortality in several human cancer forms. Experimental models are used to unravel the mechanisms and identify possible treatment targets. The location inside the skeleton complicates accurate assessment. This study
Externí odkaz:
https://doaj.org/article/c9ef7a4f6d49406687fdffc3de0c1e33
Autor:
Elin Thysell, Linda Köhn, Julius Semenas, Helena Järemo, Eva Freyhult, Marie Lundholm, Camilla Thellenberg Karlsson, Jan‐Erik Damber, Anders Widmark, Sead Crnalic, Andreas Josefsson, Karin Welén, Rolf J. A. Nilsson, Anders Bergh, Pernilla Wikström
Publikováno v:
Molecular Oncology, Vol 16, Iss 4, Pp 846-859 (2022)
To improve treatment of metastatic prostate cancer, the biology of metastases needs to be understood. We recently described three subtypes of prostate cancer bone metastases (MetA‐C), based on differential gene expression. The aim of this study was
Externí odkaz:
https://doaj.org/article/65f5c75dc7eb47b6a1f8e39de3159faa
Autor:
Tom A. Bäck, Karin Jennbacken, Malin Hagberg Thulin, Sture Lindegren, Holger Jensen, Tove Olafsen, Paul J. Yazaki, Stig Palm, Per Albertsson, Jan-Erik Damber, Anna M. Wu, Karin Welén
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-12 (2020)
Abstract Purpose Targeted alpha therapy (TAT) is a promising treatment for micrometastatic and minimal residual cancer. We evaluated systemic α-radioimmunotherapy (α-RIT) of metastatic castration-resistant prostate cancer (mCRPC) using the α-parti
Externí odkaz:
https://doaj.org/article/cb79622cfe444d258013759e1047e094
Autor:
Karin Welén, Anna K Överby, Clas Ahlm, Eva Freyhult, David Robinsson, Anna Jonsson Henningsson, Johan Stranne, Daniel Bremell, Martin Angelin, Elisabeth Lindquist, Robert Buckland, Camilla Thellenberg Carlsson, Karlis Pauksens, Anna Bill-Axelsson, Olof Akre, Cecilia Ryden, Magnus Wagenius, Anders Bjartell, Anna C. Nilsson, Johan Styrke, Johanna Repo, Åse Östholm Balkhed, Katarina Niward, Magnus Gisslén, Andreas Josefsson
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-3 (2021)
Abstract Objectives The main goal of the COVIDENZA trial is to evaluate if inhibition of testosterone signalling by enzalutamide can improve the outcome of patients hospitalised for COVID-19. The hypothesis is based on the observation that the majori
Externí odkaz:
https://doaj.org/article/6eef737882e447dd8478f0b7774aad97